FDA PRODUCT CODE · CLASS II

GXY — Electrode, Cutaneous

What these counts are not

Clearance and recall counts are SPEQ’s aggregation of FDA’s own published records for the code. A recall count is a measure of history, not of a device’s safety, neither number is an FDA rating, and SPEQ is not affiliated with the FDA.

DEVICE CLASS
Class II
REGULATION
21 CFR 882.1320
MEDICAL SPECIALTY
Neurology
REVIEW PANEL
NE
— Implant— Life-sustaining— GMP-exempt✓ Third-party review eligible
19
510(K)/PMA CLEARANCES
510k: 19
11
RECALL ENTRIES

What this classification requires

Every statement below is FDA’s own classification record for this product code, quoted from the device classification field reference. The SPEQ reading beneath each one is SPEQ’s interpretation of what it means for the work, and is not FDA text.

PREMARKET PATHWAY

510(K)

SPEQ READINGA premarket notification under 21 CFR Part 807 Subpart E is the route for this code. The submission argues substantial equivalence to a legally marketed predicate, so the engineering question is which predicate the design can actually be compared against, and the evidence question is what testing supports that comparison.

DEVICE CLASS

Class II (moderate to high risk): general controls and special controls

SPEQ READINGSpecial controls are the distinguishing feature: performance standards, guidance documents, patient registries or postmarket surveillance named for the device type. Find the special controls before designing the test plan — they usually name the tests.

MALFUNCTION REPORTING

Device is not eligible for The Voluntary Malfunction Summary Reporting Program

SPEQ READINGIndividual malfunction reporting under 21 CFR Part 803 applies. The complaint-handling system has to produce a decision per event, not per period.

GMP / QUALITY SYSTEM

Not exempt due to Good Manufacturing Practice (GMP)/Quality System

SPEQ READINGThe full Quality Management System Regulation (21 CFR 820, incorporating ISO 13485:2016) applies, and is what an FDA inspection of this device will be conducted against.

IMPLANT

Device is not implantable

SPEQ READINGNo implant-specific expectations attach from the classification itself.

LIFE-SUSTAINING

Device is not used for life sustaining purposes

SPEQ READINGNo life-sustaining designation attaches to this code.

THIRD-PARTY REVIEW

Device is a candidate for a third party review program

SPEQ READINGAn Accredited Person may conduct the 510(k) review instead of FDA. FDA still makes the clearance decision — third-party review changes who reviews, never who decides.

21 CFR 882.1320 — Cutaneous electrode

The classification regulation for this product code, as published by the Office of the Federal Register. This is the regulation text itself — no SPEQ interpretation appears in it.

(a) Identification. A cutaneous electrode is an electrode that is applied directly to a patient's skin either to record physiological signals (e.g., the electroencephalogram) or to apply electrical stimulation.

(b) Classification. Class II (performance standards).

Source: Electronic Code of Federal Regulations, Title 21. 21 CFR is a work of the United States Government and is in the public domain. SPEQ read this section on October 22, 2026. CFR is amended continuously, so verify against the source before acting on it: read 21 CFR 882.1320 on eCFR →

Recent clearances

K262654Zhejiang Qiangnao Technology Co.,Ltd · 510k2026-08-27
K260578Ambu A/S · 510k2026-07-14
K261442Cadwell Industries, Inc. · 510k2026-06-26
K261522Biowave Corporation · 510k2026-06-03
K253237Elde Medikal Sanayi ve Ticaret Anonim Sirketi · 510k2026-05-08
K254183Technomed Europe · 510k2026-05-07
K252439Dongguan Tutamen Metalwork Co., Ltd. · 510k2026-05-01
K253256Otto Bock Healthcare Products GmbH · 510k2026-04-22

Recent recalls

Coapt LLCOpen, Classified · 2023-10-31

Patient may experience minor burn or blistering if device is exposed to direct sunlight and/or warm temperatures for over 12 hours or battery is damaged.

Coapt LLCOpen, Classified · 2023-10-31

Patient may experience minor burn or blistering if device is exposed to direct sunlight and/or warm temperatures for over 12 hours or battery is damaged.

NAImco Inc dba Richmar IncTerminated · 2013-02-14

Electrode Socket Terminal pulling away from the electrode lead wire when the electrical stim lead wire was removed.

NAImco Inc dba Richmar IncTerminated · 2013-02-14

Electrode Socket Terminal pulling away from the electrode lead wire when the electrical stim lead wire was removed.

NAImco Inc dba Richmar IncTerminated · 2013-02-14

Electrode Socket Terminal pulling away from the electrode lead wire when the electrical stim lead wire was removed.

NAImco Inc dba Richmar IncTerminated · 2013-02-14

Electrode Socket Terminal pulling away from the electrode lead wire when the electrical stim lead wire was removed.

Covidien LLC dba Uni-PatchTerminated · 2012-12-10

Covidien is conducting a voluntary recall regarding specific lots of TENS electrodes because it was determined that during the manufacturing process the surface of the wires in these lots may have been exposed to an employee who had a minor cut.

Covidien LLC dba Uni-PatchTerminated · 2012-12-10

Covidien is conducting a voluntary recall regarding specific lots of TENS electrodes because it was determined that during the manufacturing process the surface of the wires in these lots may have been exposed to an employee who had a minor cut.

Source: FDA device classification, 510(k)/PMA, and recall datasets. Recall entries count distinct FDA recall numbers, so one recall event affecting several products appears as several entries. Browse every product code SPEQ tracks →